Home/Filings/4/0001415889-25-001683
4//SEC Filing

Conway Kevin John 4

Accession 0001415889-25-001683

CIK 0001733294other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:05 PM ET

Size

8.6 KB

Accession

0001415889-25-001683

Insider Transaction Report

Form 4
Period: 2025-01-15
Conway Kevin John
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-15+58717,649 total
  • Tax Payment

    Common Stock

    2025-01-15$0.89/sh204$18117,445 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-155874,694 total
    Common Stock (587 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F2]The grant of 9,390 restricted stock units was made on January 20, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0002051408

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:05 PM ET
Size
8.6 KB